Periodontal status of the Rheumatoid Arthritis patients under rituximab treatment: A case control Study

Not Applicable

Completed

• Conditions: Periodontal health; Periodontitis, Rheumatoid arthritis, B- cell depletion, IL- 1b, MMP- 8

• Registration Number: TCTR20191215003
• Lead Sponsor: Akdeniz University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-12-08
• Study Start: 2019-12-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

To be under rituximab or DMARD treatment for RA

Exclusion Criteria

To have diabetes, CVD, pregnant and smoking

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IL-1b, MMP-8 30 sec NG/30sec

Secondary Outcome Measures

Name	Time	Method
Behavior outcome Baseline, Post immediately, follow up at 1 week assessment tool